1 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07109962 2023-04-01 2024-03-31 07109962 2024-03-31 07109962 2023-03-31 07109962 2022-04-01 2023-03-31 07109962 2023-03-31 07109962 2022-03-31 07109962 bus:RegisteredOffice 2023-04-01 2024-03-31 07109962 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 07109962 bus:Agent1 2023-04-01 2024-03-31 07109962 bus:Director1 2023-04-01 2024-03-31 07109962 core:WithinOneYear 2024-03-31 07109962 core:WithinOneYear 2023-03-31 07109962 core:ShareCapital 2024-03-31 07109962 core:ShareCapital 2023-03-31 07109962 core:RetainedEarningsAccumulatedLosses 2024-03-31 07109962 core:RetainedEarningsAccumulatedLosses 2023-03-31 07109962 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 07109962 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 07109962 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 07109962 core:Non-currentFinancialInstruments 2024-03-31 07109962 core:Non-currentFinancialInstruments 2023-03-31 07109962 bus:Director1 2023-03-31 07109962 bus:Director1 2024-03-31 07109962 bus:Director1 2023-03-31 07109962 bus:Director1 2022-04-01 2023-03-31 07109962 bus:SmallEntities 2023-04-01 2024-03-31 07109962 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 07109962 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 07109962 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07109962 bus:AbridgedAccounts 2023-04-01 2024-03-31
Company registration number: 07109962
Ravenscourt Dental Practice Limited
Unaudited filleted abridged financial statements
31 March 2024
Ravenscourt Dental Practice Limited
Contents
Directors and other information
Abridged statement of financial position
Notes to the financial statements
Ravenscourt Dental Practice Limited
Directors and other information
Director Dr Hitesh Batavia
Company number 07109962
Registered office 43 Overstone Road
London
W6 0AD
Business address 5 Ravenscourt Avenue
London
W6 0SL
Accountants Michael Leong and Company
43 Overstone Road
London W6 0AD
Bankers Santander UK Plc
BBAM
Bridle Road
Bootle
Merseyside L30 4GB
Lloyds TSB Plc
195-197 Edgware Road
Paddington
London W2 1ET
Ravenscourt Dental Practice Limited
Abridged statement of financial position
31 March 2024
2024 2023
Note £ £ £ £
Fixed assets
Investments 5 166,105 154,639
_______ _______
166,105 154,639
Current assets
Debtors 243 382,267
Investments 6 3,561,413 2,855,724
Cash at bank and in hand 821,345 601,473
_______ _______
4,383,001 3,839,464
Creditors: amounts falling due
within one year ( 344,348) ( 366,479)
_______ _______
Net current assets 4,038,653 3,472,985
_______ _______
Total assets less current liabilities 4,204,758 3,627,624
Provisions for liabilities ( 137,644) ( 175,599)
_______ _______
Net assets 4,067,114 3,452,025
_______ _______
Capital and reserves
Called up share capital 1 1
Profit and loss account 4,067,113 3,452,024
_______ _______
Shareholder funds 4,067,114 3,452,025
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements were approved by the board of directors and authorised for issue on 19 July 2024 , and are signed on behalf of the board by:
Dr Hitesh Batavia
Director
Company registration number: 07109962
Ravenscourt Dental Practice Limited
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is C/O Michael Leong and Company, 43 Overstone Road, London, W6 0AD.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Investments
£
Cost
At 1 April 2023 154,639
Additions 11,466
_______
At 31 March 2024 166,105
_______
Impairment
At 1 April 2023 and 31 March 2024 -
_______
Carrying amount
At 31 March 2024 166,105
_______
At 31 March 2023 154,639
_______
6. Investments
2024 2023
£ £
Other investments 3,561,413 2,855,724
_______ _______
7. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Dr Hitesh Batavia ( 335,358) 663 ( 334,695)
_______ _______ _______
2023
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Dr Hitesh Batavia - ( 335,358) ( 335,358)
_______ _______ _______
8. Controlling party
The company is controlled by Dr Hitesh Batavia by virtue of his shareholding.